Committed to a Cure

Over 100 types of cancers affect almost 100 million people worldwide, with 18 million new cases diagnosed each year. Data from the American Cancer Society suggests that the average person’s likelihood of developing cancer is about 1 in 3. There is still no easy answer.

ProTrials is committed to using our clinical research expertise for the critical needs of people diagnosed with cancer. More than 85% of our staff have oncology clinical trial experience across various roles and specialties. We support a wide range of study sizes, from small dose finding and proof-of-concept to large oncology multi-national clinical trials. Our work spans from early phase through pivotal and post-approval, and in numerous indications. ProTrials wants to help sponsors stop cancer in its tracks.

Oncology Experience


of all staff with Oncology Experience


Projects conducted to date


Oncology Indications


Non-Small Cell Lung Cancer

Breast Cancer
Breast Cancer – Her2-positive
Breast Cancer – Triple Negative
Colorectal Cancer
Gastric Cancer
Gastrointestinal Stromal Tumors
Leukemia – Acute Myeloid
Leukemia – Chronic Lymphocytic
Leukemia – Diffuse Well-differentiated Lymphocytic
Leukemia – Multiple Myeloma
Leukemia – Small Lymphocytic Lymphoma
Liver Cancer
Lung Cancer – Non-small Cell Lung Cancer
Lung Cancer – Small Cell Lung Cancer


Lymphoma – B-cell

Lymphoma – Follicular

Lymphoma – Mantle Cell

Lymphoma – Non-Hodgkin Lymphoma


Myelodysplastic Syndrome

Ovarian Cancer

Pancreatic Cancer


Prostate Cancer

Renal Cell Cancer

Solid Tumor

Uveal Melanoma

Oncology Case Study

“We have worked with ProTrials for years across multiple programs and value their expertise, flexibility and responsive customer service. ProTrials’ seasoned professionals have contributed both domestically and internationally, in-house and in the field, whatever our needs have been ProTrials has been our solution!”


– Sponsor, Sr. Director, Clinical Operations